Table 1.
Patient characteristics
| Characteristic | CHC | Normal controls |
|---|---|---|
| Sex | ||
| Male | 188/267 (70%) | 56/100 (56%) |
| Female | 79/267 (30%) | 44/100 (44%) |
| Ethnicity | ||
| Caucasian | 213/267 (80%) | 65 (65%) |
| Black | 6/267 (2%) | 32 (32%) |
| Latino | 32/267 (12%) | |
| Other or unknown | 16/267 (6%) | 3 (3%) |
| Age (median, IQR) | 44 (40–48) | 41.5 (31–48) |
| BMI (median, IQR) | 26.8 (25–30) | 27 (24–30) |
| ALT IU/L (median, IQR) | 87.0 (50–130) | 9 (7–13) |
| Genotype | ||
| 1 | 156/267 (58%) | na |
| 2 | 40/267 (15%) | |
| 3 | 53 (20%) | |
| 4 | 3 (1%) | |
| 6 | 2 (<1%) | |
| Unknown | 13/267 (5%) | |
| Fat grade | ||
| 0 | 130 (49%) | na |
| 1 | 92 (35%) | |
| 2 | 31 (12%) | |
| 3 | 14 (5%) | |
| Fibrosis stage | ||
| 0 | 35 (13%) | na |
| 1 | 125 (47%) | |
| 2 | 42 (16%) | |
| 3 | 35 (13%) | |
| 4 | 30 (11%) | |
| Inflammation | ||
| 0–5 | 79 (31%) | na |
| 6–10 | 110 (44%) | |
| 11–16 | 62 (25%) |
CHC, chronic hepatitis C, BMI, body mass index, ALT, alanine aminotransferase; na, not applicable.